Dharam Kumbhani is a Cardiology physician affiliated with Southwestern Medical Center. OpenAlex indexes 364 publications with 17,865 citations (h-index 63). By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Boulevard
Dallas, TX 753907201
Telephone
214-645-8000Provider last certified this registry record 26 Nov 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20256 payments
- Siemens Medical Solutions USA, Inc.Program year20251 payment
- Philips North America LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.7%Statin15.2%Rosuvastatin Calcium51%Atorvastatin Calcium49%Part D≥30 patientsBeta blocker15.1%Metoprolol Succinate77%Carvedilol23%Part D≥36 patients+ 10 more classes in this area
Metabolism & gastrointestinal
14.7%SGLT2 inhibitor11.2%Jardiance61%Farxiga39%Part D<11 patientsProton pump inhibitor1.8%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Blood & clotting
10.7%P2Y12 inhibitor5%Clopidogrel100%Part D≥18 patientsFactor Xa inhibitor2.9%Eliquis100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Journal of the American College of Cardiology
2023 - Considerations for cardiac catheterization laboratory procedures during the <scp>COVID</scp>‐19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (<scp><i>SCAI ELM</i></scp>) Members and Graduates
Catheterization and Cardiovascular Interventions
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Claus Roehrborn, MD
Southwestern Medical Center
Trish Perl, MD
Southwestern Medical Center
Lisa Vanwagner, MD
Southwestern Medical Center
Jose Joglar, MD
Southwestern Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”